Kim Sua, Hwang Jinwook, Kim Je Hyeong
Department of Critical Care Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Department of Thoracic and Cardiovascular Surgery, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Ann Thorac Med. 2022 Oct-Dec;17(4):237-240. doi: 10.4103/atm.atm_265_22. Epub 2022 Oct 7.
Although the routine use of alkali buffer is not recommended in patients with respiratory acidosis, some patients may benefit from its administration. A 42-year-old man was treated with venovenous extracorporeal membrane oxygenation (VV-ECMO) and continuous venovenous hemodiafiltration (CVVHDF) due to necrotizing pneumonia and emphysematous cystitis with . Although the sweep gas flow rate of the VV-ECMO was gradually reduced, he failed to wean off VV-ECMO due to respiratory acidosis, followed by tachycardia and tachypnea on the 63rd day of VV-ECMO. Therefore, we mixed sodium bicarbonate in the replacement fluid of CVVHDF for 5 days to avoid an intolerable decrease in blood pH after discontinuing the VV-ECMO sweep gas. When the serum bicarbonate concentration was >30 mmol/L and pH was maintained at >7.30 with a PCO2 of >60 mmHg, VV-ECMO was finally decannulated. Sodium bicarbonate buffer through the replacement of CVVHDF fluid facilitated VV-ECMO weaning in a patient with hypercapnic respiratory failure.
尽管不建议在呼吸性酸中毒患者中常规使用碱性缓冲剂,但某些患者可能会从其使用中获益。一名42岁男性因坏死性肺炎和气肿性膀胱炎接受了静脉-静脉体外膜肺氧合(VV-ECMO)和持续静脉-静脉血液透析滤过(CVVHDF)治疗。尽管VV-ECMO的扫气流量逐渐降低,但由于呼吸性酸中毒,他在VV-ECMO治疗的第63天未能撤机,随后出现心动过速和呼吸急促。因此,我们在CVVHDF的置换液中加入碳酸氢钠5天,以避免在停止VV-ECMO扫气后血pH值出现难以耐受的下降。当血清碳酸氢盐浓度>30 mmol/L且pH值维持在>7.30,动脉血二氧化碳分压>60 mmHg时,最终拔除了VV-ECMO导管。通过CVVHDF置换液使用碳酸氢钠缓冲剂有助于一名高碳酸血症呼吸衰竭患者撤机。